peptide
Owlstone Medical, Bicycle Therapeutics Ink Research Agreement on Early Cancer Detection
The companies plan to combine Bicycle's proprietary bicyclic peptides with Owlstone's exogenous volatile organic compound probes for cancer detection.
Investment Banks Upgrade Quidel Shares on Acquisition of Alere Assets
Canaccord and William Blair also increased their price targets on Quidel's shares, following its acquisition of certain Alere assets and assays.